22nd Century Group, Inc. (XXII)
After hours:
| Previous Close | 2.5700 |
| Open | 2.6550 |
| Bid | 2.3800 x 2900 |
| Ask | 2.4600 x 36900 |
| Day's Range | 2.2100 - 2.6900 |
| 52 Week Range | 1.4200 - 4.9800 |
| Volume | |
| Avg. Volume | 1,878,403 |
| Market Cap | 393.85M |
| Beta (5Y Monthly) | 2.01 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1670 |
| Earnings Date | Mar 09, 2022 - Mar 14, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.50 |
- GlobeNewswire
22nd Century Group (Nasdaq: XXII) Supports Federal Proposal to Require Less Nicotine in All U.S. Cigarettes
FDA’s Proposed Rule Draws on Research That Supports Reduced Nicotine Content Cigarettes Are Less Addictive22nd Century Group’s FDA MRTP Authorized 95% Reduced Nicotine Cigarette Products Is Already Available to Meet Proposed Policy to Reduce Nicotine in All CigarettesVLN® Pilot Sales Across Circle K Stores in the Chicago Area Showing Strong Interest from Adult Smokers BUFFALO, N.Y., June 22, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology co
- GlobeNewswire
22nd Century Group (Nasdaq: XXII) Appoints R. Hugh Kinsman as CFO
CFO of GVB Biopharma to Expand Role, Become CFO of 22nd Century GroupIntegration of GVB Biopharma Proceeding at a Rapid Pace BUFFALO, N.Y., June 16, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company), dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology, today announced the appointment of R. Hugh Kinsman as Chief Financial Officer. Kinsman is currently CFO of GVB Biopharma
- GlobeNewswire
22nd Century Group (Nasdaq: XXII) to Participate in LD Micro, Roth Capital Investor Meetings
BUFFALO, N.Y., May 27, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology, today announced that James A. Mish, Chief Executive Officer, and Richard Fitzgerald, Chief Financial Officer, will host meetings with investors at two upcoming investor conference events in June 2022. Event:LD Micro Invitational XII (in person)Date
